China Wholesale Crema Cu Ceramide Rnw Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

The incredibly rich projects administration experiences and a person to 1 service model make the substantial importance of organization communication and our easy understanding of your expectations for Vitamin A , Zinc Oxide For Lips , Sun Care , We are keeping durable small business relationships with additional than 200 wholesalers in the USA, the UK, Germany and Canada. For anyone who is intrigued in any of our products, make sure you experience free to speak to us.
China Wholesale Crema Cu Ceramide Rnw Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma Detail:

Product Paramete

Trade name PromaCare-TA
CAS 1197-18-8
Product Name Tranexamic Acid
Chemical Structure
Application Medicine
Package 25kgs net per drum
Appearance White or almost white, crystalline power
Assay 99.0-101.0%
Solubility Water soluble
Shelf life 4 years
Storage Keep container tightly closed and in a cool place. Keep away from heat.

Application

Tranexamic Acid, also known as clotting acid, is an antifibrinolytic amino acid, which is one of the commonly used anticoagulants in clinic

This product can be used for:

1. Trauma or surgical bleeding of prostate, urethra, lung, brain, uterus, adrenal gland, thyroid, liver and other organs rich in plasminogen activator.

2. They are used as thrombolytic agents, such as tissue plasminogen activator (t-PA), streptokinase and urokinase antagonist.

3. Induced abortion, placental exfoliation, stillbirth and amniotic fluid embolism caused by fibrinolytic bleeding.

4. Menorrhagia, anterior chamber hemorrhage and severe epistaxis with increased local fibrinolysis.

5. It is used to prevent or reduce bleeding after tooth extraction or oral surgery in hemophilic patients with factor VIII or factor IX deficiency.

6. This product is superior to other antifibrinolytic drugs in hemostasis of mild hemorrhage caused by rupture of central aneurysm, such as subarachnoid hemorrhage and intracranial aneurysm hemorrhage. However, attention must be paid to the risk of cerebral edema or cerebral infarction. As for severe patients with surgical indications, this product can only be used as an adjuvant.

7. For the treatment of hereditary vascular edema, can reduce the number of attacks and severity.

8. Patients with hemophilia have active bleeding.

9. It has definite curative effect on chloasma.


Product detail pictures:

China Wholesale Crema Cu Ceramide Rnw Factory Suppliers - PromaCare-TA / Tranexamic Acid  – Uniproma detail pictures


Related Product Guide:

"Sincerity, Innovation, Rigorousness, and Efficiency" would be the persistent conception of our corporation to the long-term to establish collectively with customers for mutual reciprocity and mutual benefit for China Wholesale Crema Cu Ceramide Rnw Factory Suppliers - PromaCare-TA / Tranexamic Acid – Uniproma, The product will supply to all over the world, such as: belarus, Morocco, Las Vegas, We've got constructed strong and long co-operation relationship with an enormous quantity of companies within this business in Kenya and overseas. Immediate and professional after-sale service supplied by our consultant group has happy our buyers. Thorough Info and parameters from the merchandise will probably be sent for you for any thorough acknowledge. Free samples may be delivered and company check out to our corporation. n Kenya for negotiation is constantly welcome. Hope to get inquiries type you and construct a long-term co-operation partnership.
  • This supplier's raw material quality is stable and reliable, has always been in accordance with the requirements of our company to provide the goods that quality meet our requirements.
    5 Stars By Debby from United States - 2018.05.13 17:00
    The enterprise has a strong capital and competitive power, product is sufficient, reliable, so we have no worries on cooperating with them.
    5 Stars By jari dedenroth from Southampton - 2018.11.28 16:25